N-acetyl leucomethylene blue

ID: ALA4789463

Cas Number: 3763-06-2

PubChem CID: 19825832

Max Phase: Preclinical

Molecular Formula: C18H21N3OS

Molecular Weight: 327.45

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N1c2ccc(N(C)C)cc2Sc2cc(N(C)C)ccc21

Standard InChI:  InChI=1S/C18H21N3OS/c1-12(22)21-15-8-6-13(19(2)3)10-17(15)23-18-11-14(20(4)5)7-9-16(18)21/h6-11H,1-5H3

Standard InChI Key:  JEOGFTYLESYHAM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   15.5968   -4.0736    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.5968   -2.4392    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3149   -3.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9034   -3.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0207   -4.0736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2100   -4.0736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9034   -2.8478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3149   -2.8478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7471   -3.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4754   -3.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7820   -4.0736    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4754   -2.8478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7471   -2.8478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2100   -2.4392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0207   -2.4392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0887   -3.6485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7820   -4.8866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5906   -1.6220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2952   -1.2081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8798   -1.2188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4577   -4.0437    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.4635   -4.8609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1625   -3.6301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  7  1  0
  3  1  1  0
  4  1  1  0
  5  3  1  0
  6  4  2  0
  7  4  1  0
  8  3  2  0
  9  5  2  0
 10  6  1  0
 11 10  1  0
 12 14  1  0
 13 15  2  0
 14  7  2  0
 15  8  1  0
 16 11  1  0
 17 11  1  0
  2  8  1  0
 12 10  2  0
 13  9  1  0
  2 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21 22  1  0
 21 23  1  0
M  END

Associated Targets(Human)

Lymphocyte (105 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 327.45Molecular Weight (Monoisotopic): 327.1405AlogP: 3.97#Rotatable Bonds: 2
Polar Surface Area: 26.79Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.55CX LogP: 3.16CX LogD: 3.16
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.83Np Likeness Score: -0.77

References

1. Liu J,Bandyopadhyay I,Zheng L,Khdour OM,Hecht SM.  (2020)  Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease.,  11  (11): [PMID:33214825] [10.1021/acsmedchemlett.0c00293]

Source